Turtle Cameron Insider Trades & Stock Holdings

Chief Executive Officer · Spyre Therapeutics, Inc. · Latest filing Oct 1, 2026

Turtle Cameron, Chief Executive Officer at Spyre Therapeutics, Inc. has 1 Form 4 trade on file since Oct 1, 2026. Open-market activity: 0 purchases ($0) and 1 sale ($1.38M), net -$1.38M. Latest filing: disposed of 15K shares of $SYRE on Oct 1, 2026 at $92.01.

Trades on file

1

Open-market bought

$0

Open-market sold

$1.38M

Net open-market

-$1.38M

Latest filing

Oct 1, 2026

All insider trades by Turtle Cameron

Date	Ticker	Type	Shares	Price	Value	Owned after	ΔOwn	1W	1M	6M	Role	Filing	Story
Oct 1, 2026	$SYRE	Sell (Open-market sale) 10b5-1	15K	$92.01	$1.38M			-11.2%			Chief Executive Officer		—

"Buy" means shares acquired on the Form 4 (including grants and option exercises); "Sell" means shares disposed. 1W / 1M / 6M = how the stock moved after the trade.

Stocks Turtle Cameron traded

• $SYRE

Frequently asked questions

Has Turtle Cameron been buying or selling stock?

Turtle Cameron has 0 open-market purchases and 1 open-market sale on file, net -$1.38M. Grants, option exercises and tax withholding are listed separately because they are not open-market trades.

What was Turtle Cameron's latest insider trade?

disposed of 15K shares of $SYRE on Oct 1, 2026 at $92.01.

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.